Current Research Interests
Dr. Zhang’s current research interests are in survival analysis, longitudinal data analysis and semiparametric inferences. In particular, he is interested in developing methodology for data subject to complicated censorship and/or truncation, which frequently arise in clinical trials and medical studies. He is also interested in statistical research aimed at clinical trials. Dr. Zhang collaborates with colleagues in the Department of Radiation Oncology, the Department of Medical Physics and the Neuroradiology Service.
Visit PubMed for a full listing of Zhigang Zhang’s journal articlesPubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Zhigang Zhang discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].
View all disclosures